USD 39.77
(-0.11%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Revenue | 42.22 Million | 40.27 Million | 37.86 Million | 36.67 Million | 36.72 Million | 32.96 Million |
Cost of Revenue | - | - | - | - | - | - |
Gross Profit | 42.22 Million | 40.27 Million | 37.86 Million | 36.67 Million | 36.72 Million | 32.96 Million |
Operating Expenses | 42.22 Million | 1.09 Million | -24.2 Million | -24.84 Million | -24.4 Million | -20.7 Million |
Selling, General and Administrative Expenses | 15.33 Million | 15.05 Million | 14.89 Million | 14.14 Million | 13.65 Million | 12.08 Million |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | 26.88 Million | -8.55 Million | -39.09 Million | -38.99 Million | -38.06 Million | -32.79 Million |
Cost and Expenses | 42.22 Million | 1.09 Million | -24.2 Million | -24.84 Million | -24.4 Million | -20.7 Million |
Operating Income | - | 17.82 Million | 13.66 Million | 11.82 Million | 12.31 Million | 12.25 Million |
Interest Expense | 9.01 Million | 1.59 Million | 1.12 Million | 1.56 Million | 1.96 Million | 1.61 Million |
Income Tax Expense | 2.24 Million | 2.32 Million | 2.24 Million | 1.69 Million | 1.98 Million | 1.39 Million |
Earnings before Tax | 15.05 Million | 14.23 Million | 13.67 Million | 11.83 Million | 12.32 Million | 10.66 Million |
Net Income | 12.79 Million | 11.9 Million | 11.42 Million | 10.13 Million | 10.32 Million | 9.25 Million |
Earnings Per Share Basic | 3.82 | 3.55 | 3.41 | 3.03 | 3.10 | 2.78 |
Earnings Per Share Diluted | 3.82 | 3.55 | 3.41 | 3.02 | 3.09 | 2.77 |
Weighted Average Shares Outstanding | 3.34 Million | 3.35 Million | 3.34 Million | 3.33 Million | 3.33 Million | 3.32 Million |
Weighted Average Shares Outstanding (Diluted) | 3.34 Million | 3.35 Million | 3.34 Million | 3.34 Million | 3.34 Million | 3.33 Million |
Gross Margin | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
EBIT Margin | - | 0.47 | 0.39 | 0.36 | 0.36 | 0.41 |
Profit Margin | 0.30 | 0.30 | 0.30 | 0.28 | 0.28 | 0.28 |
EBITDA | - | 15.3 Million | 14.82 Million | 13.03 Million | 13.39 Million | 11.87 Million |
Earnings Before Tax Margin | - | 0.44 | 0.36 | 0.32 | 0.34 | 0.37 |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
---|---|---|---|---|---|---|
Revenue | 15.02 Million | 14.24 Million | 13.73 Million | 51.44 Million | 13.47 Million | 8.53 Million |
Cost of Revenue | - | 6000.00 | - | 207 Thousand | 995 Thousand | - |
Gross Profit | 15.02 Million | 14.24 Million | 13.73 Million | 51.23 Million | 12.47 Million | 8.53 Million |
Operating Expenses | -11.58 Million | 2.28 Million | 6.75 Million | 9.26 Million | -13.47 Million | 183 Thousand |
Selling, General and Administrative Expenses | - | 4.04 Million | 347 Thousand | - | 3.77 Million | 183 Thousand |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | -11.58 Million | -2.28 Million | -13.73 Million | -9.26 Million | -13.47 Million | -2.05 Million |
Cost and Expenses | 11.58 Million | 10.92 Million | 10.27 Million | 36.39 Million | 9.87 Million | 183 Thousand |
Operating Income | 3.43 Million | 3.32 Million | 3.46 Million | -13 Thousand | -3000.00 | 3.71 Million |
Interest Expense | - | 3.56 Million | 3.23 Million | 9.01 Million | 3.09 Million | 2.64 Million |
Income Tax Expense | 537 Thousand | 488 Thousand | 507 Thousand | 2.24 Million | 478 Thousand | 572 Thousand |
Earnings before Tax | 3.43 Million | 3.32 Million | 3.46 Million | 15.05 Million | 3.59 Million | 3.71 Million |
Net Income | 2.89 Million | 2.82 Million | 2.95 Million | 12.79 Million | 3.11 Million | 3.13 Million |
Earnings Per Share Basic | 0.87 | 0.85 | 0.88 | - | 0.93 | 0.94 |
Earnings Per Share Diluted | 0.87 | 0.85 | 0.88 | - | 0.93 | 0.94 |
Weighted Average Shares Outstanding | 3.34 Million | 3.34 Million | 3.34 Million | 3.34 Million | 3.34 Million | 3.34 Million |
Weighted Average Shares Outstanding (Diluted) | 3.34 Million | 3.34 Million | 3.34 Million | 3.34 Million | 3.34 Million | 3.34 Million |
Gross Margin | 1.00 | 1.00 | 1.00 | 1.00 | 0.93 | 1.00 |
EBIT Margin | 0.23 | -0.00 | -0.00 | - | -0.00 | 0.43 |
Profit Margin | 0.19 | 0.20 | 0.21 | 0.25 | 0.23 | 0.37 |
EBITDA | 3.43 Million | -4000.00 | -3000.00 | - | -3000.00 | 3.71 Million |
Earnings Before Tax Margin | 0.23 | 0.23 | 0.25 | -0.00 | -0.00 | 0.43 |
INL
SOLB
SMSPHARMA
000529
000953
NOKBF